Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001298588 | SCV001487649 | uncertain significance | Septo-optic dysplasia sequence; GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES | 2023-09-17 | criteria provided, single submitter | clinical testing | This sequence change replaces tryptophan, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 105 of the HESX1 protein (p.Trp105Gly). This variant is present in population databases (rs754137696, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with HESX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 492850). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mendelics | RCV002248803 | SCV002517177 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Clinical Molecular Genetics Laboratory, |
RCV000583407 | SCV000692277 | pathogenic | Septo-optic dysplasia sequence | 2008-06-03 | no assertion criteria provided | clinical testing | |
Clinical Molecular Genetics Laboratory, |
RCV000581469 | SCV000692278 | pathogenic | Pituitary hormone deficiency, combined, 1 | 2008-06-03 | no assertion criteria provided | clinical testing |